Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Drug Safety Surveillance Poses No Conflict Of Interest - Temple

Executive Summary

FDA monitoring of drug safety poses no conflict of interest within the agency, Associate Director for Medical Policy Robert Temple, MD, maintained during a Food and Drug Law Institute conference Dec. 17 in response to a New England Journal of Medicine article calling for an independent board to monitor and evaluate drug safety.

You may also be interested in...



FDA Commissioner Search Continues; Vanderbilt’s Wood Is Candidate

Vanderbilt University Vice Chancellor and FDA Nonprescription Drugs Advisory Committee Member Alastair Wood, MD, is among a new list of candidates for FDA commissioner being considered by the White House

FDA Commissioner Search Continues; Vanderbilt’s Wood Is Candidate

Vanderbilt University Vice Chancellor and FDA Nonprescription Drugs Advisory Committee Member Alastair Wood, MD, is among a new list of candidates for FDA commissioner being considered by the White House

Voluntary Financial Disclosure Guidelines Being Considered By PhRMA

PhRMA is considering the development of voluntary guidelines on financial interest disclosure for researchers publishing study results as part of a strategy to improve the pharmaceutical industry's image in a climate in which questions have arisen about investigator-sponsor relationships.

UsernamePublicRestriction

Register

ID020288

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel